PharmiWeb.com - Global Pharma News & Resources
21-Nov-2018

Infertility Treatment Market by Product, Procedure, Patient Type, End User - Global Forecasts to 2023 - ResearchAndMarkets.com

The "Infertility Treatment Market by Product, Procedure [ART, Insemination, Laparoscopy, Tubal Ligation], Patient Type, End User - Forecasts to 2023" report has been added to ResearchAndMarkets.com's offering.

The global infertility treatment market is projected to reach 2.2 billion by 2023 from USD 1.5 billion in 2018 at a CAGR of 8.0%

Growth in the infertility treatment market can be attributed to factors such as the declining fertility rate and increasing public awareness about various infertility treatment options. However, high procedural costs and unsupportive government regulations are the major factors restricting market growth.

The female infertility treatment segment is expected to hold the largest market share during the forecast period.

On the basis of patient type, the global infertility treatment market has been segmented into patient infertility treatment and male infertility treatment. The female infertility treatment segment is expected to hold the largest market share during the forecast period. Factors such as decreased rate of fertility in female population and increased range of available treatment options to overcome infertility issues are driving growth in this market segment.

The fertility centers segment is expected to grow at the highest rate during the forecast period.

On the basis of end user, the infertility treatment market is segmented into fertility centers, hospitals & surgical clinics, cryobanks, and research institutes. The fertility centers segment is expected to grow at the highest rate during the forecast period. This is mainly due to factors such as the increasing number of fertility centers across the globe and increasing medical tourism in emerging countries.

The European infertility treatment market is expected to hold the second-largest share during the forecast period.

Geographically, the infertility treatment market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World. The Europe market is expected to hold the second-largest share during the forecast period. Growth in this segment is mainly due to the declining fertility rate, growing number of fertility clinics, and increasing number of public-private investments.

Moreover, increasing medical tourism in various European countries such as Spain and Italy are also shifting the focus towards the European market, thereby driving the growth of this market during the forecast period.

Market Dynamics

Drivers

  • Declining Fertility Rate
  • Rising Number of Fertility Clinics Worldwide
  • Technological Advancements
  • Advancements in Infertility Treatment Devices
  • Increase in the Use of Time-Lapse Technology
  • Increasing Public-Private Investments, Funds, and Grants

Restraints

  • High Procedural Cost of Assisted Reproductive Techniques in Developed Markets
  • Unsupportive Government Regulations

Opportunities

  • Growth Opportunities in Emerging Markets
  • Improving Healthcare Infrastructure
  • Increasing Medical Tourism Due to Low Treatment Costs
  • Use of Fertility Treatment Options By Single Parents and Same-Sex Couples

Challenges

  • Concerns Related to Art Procedures
  • Reduced Efficacy Among Older Women

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Infertility Treatment Market, By Product

7 Infertility Treatment Market, By Procedure

8 Infertility Treatment Market, By Patient Type

9 Infertility Treatment Market, By End User

10 Infertility Treatment Market, By Region

11 Competitive Landscape

12 Company Profiles

  • Cook Group Incorporated
  • Esco Micro Pte. Ltd.
  • Genea Limited
  • Hamilton Throne, Ltd.
  • Ihmedical A/S
  • Irvine Scientific (A Member of Jx Holdings Group)
  • IVFTech Aps
  • Kitazato Corporation
  • Medgyn Products, Inc.
  • Rocket Medical PLC
  • Somatex Medical Technologies GmbH
  • The Baker Company, Inc.
  • The Cooper Companies, Inc.
  • Thermo Fisher Scientific
  • Vitrolife Ab
  • Zeiss Group

For more information about this report visit https://www.researchandmarkets.com/research/f3293d/infertility?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181121005175/en/

Editor Details

Last Updated: 21-Nov-2018